Abstract Details
Activity Number:
|
647
|
Type:
|
Contributed
|
Date/Time:
|
Thursday, August 8, 2013 : 8:30 AM to 10:20 AM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #308569 |
Title:
|
A Novel Design for Decision Rules Based on Statistical Testing Strategies in a Definitive Go/No-Go Clinical Study
|
Author(s):
|
Ming Zhou and Larry Z. Shen*+
|
Companies:
|
Amylin Pharma., LLC (a Bristol-Myers Squibb Co.) and Amylin Pharma., LLC (a Bristol-Myers Squibb Co.)
|
Keywords:
|
Statistical Testing ;
Decision Making ;
Wilson Score ;
Binary Endpoint ;
Sample Size
|
Abstract:
|
In drug development a denitive go/no-go clinical study is sometimes conducted before major investment is made to advance the development into the next stage. Such a study sometimes focuses on a key binary endpoint such as a particular adverse event or failure of a delivery device. However, such a study is often constrained by the limited budget and scope, which limits the Sponsor's ability to draw clear conclusions. This paper proposes a novel design that uses Wilson condence intervals to devise statistical testing strategies that allow the decision makers to arrive at certain denite conclusions within the constraint of the scope of the study.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2013 program
|
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.